Fig. 1From: Spectrum of Germline RET variants identified by targeted sequencing and associated Multiple Endocrine Neoplasia type 2 susceptibility in ChinaPathogenic mutations or VUS in RET for 697 subjects including MTC/PHEO cases and screened relatives by targeted sequencing. MTC risk category following the ATA-2015 and proposition of classifying variants not found in the ATA-2015 using the consensus recommendation of the ACMG-2015Back to article page